Press release
Endometriosis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2024-2034), Analyzes DelveInsight | Enteris BioPharma, Spago Nanomedical, Iqvia Pty, Myovant Sciences, others
DelveInsight's "Endometriosis Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Endometriosis, historical and forecasted epidemiology as well as the Endometriosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Endometriosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Endometriosis Market Forecast [https://www.delveinsight.com/sample-request/endometriosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Endometriosis Market Report:
*
The Endometriosis market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In November 2023, Gedeon Richter and Sumitomo Pharma jointly revealed that the European Commission had approved a Type II Variation application for RYEQO (consisting of relugolix 40 mg, estradiol 1.0 mg, and norethisterone acetate 0.5 mg). This approval pertains to the symptomatic treatment of endometriosis in women who have undergone previous medical or surgical interventions for their condition.
*
According to information from the World Health Organization (2023), approximately 10% of reproductive-age women and girls worldwide, totaling around 190 million individuals, are impacted by endometriosis.
*
In 2023, the estimated number of diagnosed prevalent cases of endometriosis in the US stood at approximately 4,800,000 cases, with a potential increase anticipated by 2034.
*
In 2023, it was noted that the largest population of individuals affected by endometriosis in the US fell within the 18-29 age bracket, with approximately 5,000,000 cases.
*
In 2023, the diagnosed prevalent cases of endometriosis categorized by pain severity in the US were approximately 1,200,000 for mild, 1,900,000 for moderate, and 1,600,000 for severe. These figures are projected to increase during our forecast period from 2024 to 2034.
*
Key Endometriosis Companies: Enteris BioPharma Inc., Spago Nanomedical AB, Iqvia Pty Ltd, Nanjing Chia-tai Tianqing Pharmaceutical, Myovant Sciences GmbH, Hope Medicine (Nanjing) Co., Ltd, Ferring Pharmaceuticals, Jiangsu HengRui Medicine, ObsEva, AbbVie, ASKA Pharmaceutical Co., Ltd., Abbott, Kissei Pharmaceutical Co., Ltd., Bayer, Pfizer, and others
*
Key Endometriosis Therapies: Leuprolide Oral Tablet, SN132D, OG-6219, Elagolix, Relugolix, HMI-115, Quinagolide 1080 g, OBE2109, SASHR7280, Estradiol/Norethindrone Acetate, TAK-385, NBI-56418 (GnRH antagonist), KLH-2109, Dienogest (Visanne, BAY86-5258), ERB-041, and others
*
As per the findings of Yoshino et al. (2022), around 2.6 million women in Japan are impacted by endometriosis.
*
The Endometriosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Endometriosis pipeline products will significantly revolutionize the Endometriosis market dynamics.
Endometriosis Overview
Endometriosis is a chronic condition where tissue similar to the lining of the uterus grows outside the uterus. This tissue behaves like uterine lining, thickening and bleeding during the menstrual cycle. However, as it's displaced, it becomes trapped, leading to pain, inflammation, and sometimes fertility issues.
Get a Free sample for the Endometriosis Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/endometriosis-market [https://www.delveinsight.com/report-store/endometriosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Endometriosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Endometriosis Epidemiology Segmentation:
The Endometriosis market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Endometriosis
*
Prevalent Cases of Endometriosis by severity
*
Gender-specific Prevalence of Endometriosis
*
Diagnosed Cases of Episodic and Chronic Endometriosis
Download the report to understand which factors are driving Endometriosis epidemiology trends @ Endometriosis Epidemiology Forecast [https://www.delveinsight.com/sample-request/endometriosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Endometriosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Endometriosis market or expected to get launched during the study period. The analysis covers Endometriosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Endometriosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Endometriosis Therapies and Key Companies
*
Leuprolide Oral Tablet: Enteris BioPharma Inc.
*
SN132D: Spago Nanomedical AB
*
OG-6219: Iqvia Pty Ltd
*
Elagolix: Nanjing Chia-tai Tianqing Pharmaceutical
*
Relugolix: Myovant Sciences GmbH
*
HMI-115: Hope Medicine (Nanjing) Co., Ltd
*
Quinagolide 1080 g: Ferring Pharmaceuticals
*
OBE2109: ObsEva
*
SASHR7280: Jiangsu HengRui Medicine
*
Estradiol/Norethindrone Acetate: AbbVie
*
TAK-385: ASKA Pharmaceutical Co., Ltd.
*
NBI-56418 (GnRH antagonist): Abbott
*
KLH-2109: Kissei Pharmaceutical Co., Ltd.
*
Dienogest (Visanne, BAY86-5258): Bayer
*
ERB-041: Pfizer
Discover more about therapies set to grab major Endometriosis market share @ Endometriosis Treatment Landscape [https://www.delveinsight.com/sample-request/endometriosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Endometriosis Market Strengths
*
The rising prevalence of endometriosis is the primary strength of its global market, leading to more focus by pharmaceutical firms
*
At national and international levels, government and key market players actively invest in research and development and increase funds, further catering to market growth.
Endometriosis Market Opportunities
*
Incumbents are paired with healthcare providers to raise awareness in the field of endometriosis at the physician and patient levels
*
New diagnostic tools and techniques or methods can be explored for the early detection of endometriosis in the affected patient pool
Scope of the Endometriosis Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Endometriosis Companies: Enteris BioPharma Inc., Spago Nanomedical AB, Iqvia Pty Ltd, Nanjing Chia-tai Tianqing Pharmaceutical, Myovant Sciences GmbH, Hope Medicine (Nanjing) Co., Ltd, Ferring Pharmaceuticals, Jiangsu HengRui Medicine, ObsEva, AbbVie, ASKA Pharmaceutical Co., Ltd., Abbott, Kissei Pharmaceutical Co., Ltd., Bayer, Pfizer, and others
*
Key Endometriosis Therapies: Leuprolide Oral Tablet, SN132D, OG-6219, Elagolix, Relugolix, HMI-115, Quinagolide 1080 g, OBE2109, SASHR7280, Estradiol/Norethindrone Acetate, TAK-385, NBI-56418 (GnRH antagonist), KLH-2109, Dienogest (Visanne, BAY86-5258), ERB-041, and others
*
Endometriosis Therapeutic Assessment: Endometriosis current marketed and Endometriosis emerging therapies
*
Endometriosis Market Dynamics: Endometriosis market drivers and Endometriosis market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Endometriosis Unmet Needs, KOL's views, Analyst's views, Endometriosis Market Access and Reimbursement
To know more about Endometriosis companies working in the treatment market, visit @ Endometriosis Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/endometriosis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Endometriosis Market Report Introduction
2. Executive Summary for Endometriosis
3. SWOT analysis of Endometriosis
4. Endometriosis Patient Share (%) Overview at a Glance
5. Endometriosis Market Overview at a Glance
6. Endometriosis Disease Background and Overview
7. Endometriosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Endometriosis
9. Endometriosis Current Treatment and Medical Practices
10. Endometriosis Unmet Needs
11. Endometriosis Emerging Therapies
12. Endometriosis Market Outlook
13. Country-Wise Endometriosis Market Analysis (2020-2034)
14. Endometriosis Market Access and Reimbursement of Therapies
15. Endometriosis Market Drivers
16. Endometriosis Market Barriers
17. Endometriosis Appendix
18. Endometriosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=endometriosis-market-is-predicted-to-exhibit-remarkable-growth-during-the-forecast-period-20242034-analyzes-delveinsight-enteris-biopharma-spago-nanomedical-iqvia-pty-myovant-sciences-others]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endometriosis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2024-2034), Analyzes DelveInsight | Enteris BioPharma, Spago Nanomedical, Iqvia Pty, Myovant Sciences, others here
News-ID: 3476743 • Views: …
More Releases from ABNewswire
Patient Comfort Prioritized by Orthodontist in Gainesville GA with Modernized Pr …
Patients now expect not only effective treatments but also a more positive and stress-free experience. As technology evolves, leading practices are modernizing their methods to meet these demands.
Advancing Orthodontic Care in Gainesville
The growing need for comprehensive dental solutions has brought increased attention to the role of an orthodontist Gainesville GA [https://www.google.com/search?orthodontist+Gainesville+GA&kgmid=/g/11tf41mhhd] in ensuring both comfort and long-term oral health. Patients now expect not only effective treatments but also a more…
Elite Remodels Las Vegas: Transforming Homes Into Dream Spaces With Unmatched Cr …
Elite Remodels Las Vegas, a leading name in high-quality home renovation and design, is redefining the remodeling experience for homeowners across the Las Vegas Valley. With over a decade of expertise, a client-first approach, and a passion for delivering spaces that reflect individuality and style, Elite Remodels continues to set the benchmark for excellence in home transformation.
Las Vegas, NV - Elite Remodels Las Vegas, a leading name in high-quality home…
"Nigerian Cowboy" - A Bold New Novel Blending African Roots with the Spirit of t …
What happens when a Nigerian boy dares to dream of becoming a cowboy? In his groundbreaking debut novel, Nigerian Cowboy , Dr. Emmanuel X. Okoro takes readers on a journey that fuses African identity, Western grit, and the timeless pursuit of belonging.
From a small Nigerian village to the sprawling ranches of Texas, Nigerian Cowboy follows Jacob Obi, a dreamer determined to prove that courage knows no borders. Through trials, rivalries,…
Dr. Yehuda Lehrfield of The Smile Design Center Offers Expert Tips for Long-Last …
Dr. Yehuda Lehrfield of The Smile Design Center in Owings Mills, MD, shares expert tips for lasting oral health, emphasizing daily care, regular checkups, and the link between oral health and overall wellness. The center also specializes in personalized Dental Implants to restore missing teeth.
Owings Mills, MD - Dr. Yehuda Lehrfield, founder of The Smile Design Center, is sharing expert tips on maintaining long-lasting oral health in Owings Mills, MD.…
More Releases for Endometriosis
Endometriosis Pain Market Massive Growth opportunity Ahead
Introduction
Endometriosis is a chronic, estrogen-dependent condition in which endometrial-like tissue grows outside the uterus, leading to inflammation, scarring, and adhesions. One of its most debilitating symptoms is pelvic pain, often accompanied by painful periods, infertility, and fatigue. Globally, endometriosis affects an estimated 10% of women of reproductive age, making it a major public health concern.
Despite its prevalence, endometriosis pain has historically been underdiagnosed and undertreated. Patients often face diagnostic delays…
Hope for Rapid, Non-Invasive Endometriosis Diagnosis
New diagnostic test for endometriosis, the ENDOSURE test, offers decision support to clinicians with 99.87% accurate results in less than an hour, could transform women's healthcare
EDMONTON, AB - In a groundbreaking development for women's health featured on Global News Calgary by journalist Jayme Doll on March 12, 2025, the ENDOSURE test emerges as a beacon of hope for millions suffering from undiagnosed endometriosis in. This non-invasive diagnostic tool promises to…
Emerging Endometriosis Market Trend 2025-2034: Innovative Medications Reshaping …
"How Is the Endometriosis Market Projected to Grow, and What Is Its Market Size?
The endometriosis market has seen rapid growth in recent years. It is expected to grow from $1.4 billion in 2024 to $1.55 billion in 2025, at a compound annual growth rate (CAGR) of 10.2%. The growth can be attributed to delayed diagnosis, increased awareness, advances in laparoscopic surgery, hormonal therapies, and the support of patient advocacy groups.
The…
Endometriosis Treatment Market Analysis, Size, Share & Trends | 2031
In recent years, the global Endometriosis Treatment Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Endometriosis Treatment Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Endometriosis Market Size, Share, Insight, Treatment 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Endometriosis Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $2.01 billion In 2028 At A…
Endometriosis Market Trends, Size, Forecast - 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and…
